India: Top artists to showcase work at exhibition in support of cancer patients
Web report/Mumbai
Photo: Twitter
Art exhibition-cum-sale to feature the works of 24 artists from across the country
The Covid pandemic has caused devastating interruptions in treatment for scores of cancer patients, says Shubha Maudgal of the Cancer Patients Aid Association (CPAA), Mumbai, which is organising its visual art exhibition-cum-sale to support patients.
‘Colours of Life,’ its popular event has been virtual since 2020 after the outbreak of the pandemic. This year, the event showcases an eclectic mix of colours, textures and themes by 24 artists from across India through their 48 works.
India’s Defence Research and Development Organisation (DRDO) has developed an anti-Coronavirus drug which is probably first of its kind in the world. This
2021-05-17 12:35:56 GMT2021-05-17 20:35:56(Beijing Time) Xinhua English
NEW DELHI, May 17 (Xinhua) The Indian government Monday launched the first batch of its indigenous anti-COVID-19 drug, 2-deoxy-D-glucose (2-DG).
The drug developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of India s Defence Research and Development Organisation (DRDO) in collaboration with Dr. Reddy s Laboratories (DRL), in the southern city Hyderabad, is used to treat COVID-19 patients.
The first batch of the drug was handed over by the federal defense minister Rajnath Singh to the federal health minister Harsh Vardhan in the national capital New Delhi.
The 2-DG drug was recently given approval for emergency use from the Drugs Controller General of India.